Payment overview · 2025
General Payments
$212.66
4 reported records · 3 companies
Healthcare provider profile · identity verified
Rahul Gupta, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · FAIRFIELD, CT · NPI 1245421213
Verified facts
What the public records show
CMS Open Payments records show Rahul Gupta, M.D. received $212.66 in general payments during 2025 across 4 reported records.
Abbott Laboratories accounted for 70.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $149.93 | 70.5% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $47.56 | 22.4% | 2 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $15.17 | 7.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $212.66 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NAVITOR Normalized: navitor |
Device | Abbott Laboratories | $149.93 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $47.56 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $15.17 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 877 | 187 |
| Amlodipine Besylate | Amlodipine Besylate | 782 | 166 |
| Levothyroxine Sodium | Levothyroxine Sodium | 704 | 141 |
| Furosemide | Furosemide | 481 | 83 |
| Trazodone Hcl | Trazodone Hcl | 449 | 91 |
| Losartan Potassium | Losartan Potassium | 428 | 92 |
| Eliquis | Apixaban | 421 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 359 | 84 |
| Lisinopril | Lisinopril | 355 | 84 |
| Donepezil Hcl | Donepezil Hcl | 345 | 65 |
| Mirtazapine | Mirtazapine | 320 | 61 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 316 | 79 |
| Gabapentin | Gabapentin | 298 | 66 |
| Metoprolol Succinate | Metoprolol Succinate | 290 | 73 |
| Escitalopram Oxalate | Escitalopram Oxalate | 277 | 75 |
| Metformin Hcl | Metformin Hcl | 249 | 59 |
| Tamsulosin Hcl | Tamsulosin Hcl | 243 | 68 |
| Omeprazole | Omeprazole | 240 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 239 | 48 |
| Sertraline Hcl | Sertraline Hcl | 236 | 51 |
| Memantine Hcl | Memantine Hcl | 218 | 42 |
| Simvastatin | Simvastatin | 180 | 39 |
| Quetiapine Fumarate | Quetiapine Fumarate | 179 | 40 |
| Carvedilol | Carvedilol | 173 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 144 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 139 | 30 |
| Famotidine | Famotidine | 138 | 32 |
| Divalproex Sodium | Divalproex Sodium | 129 | 27 |
| Jardiance | Empagliflozin | 126 | 25 |
| Potassium Chloride | Potassium Chloride | 123 | 23 |
| Risperidone | Risperidone | 117 | 17 |
| Finasteride | Finasteride | 116 | 23 |
| Montelukast Sodium | Montelukast Sodium | 112 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 107 | 28 |
| Xarelto | Rivaroxaban | 89 | 15 |
| Atenolol | Atenolol | 88 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 88 | 23 |
| Alendronate Sodium | Alendronate Sodium | 87 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 27 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 76 | 48 |
| Fluoxetine Hcl | Fluoxetine Hcl | 73 | suppressed |
| Latanoprost | Latanoprost | 70 | 19 |
| Levetiracetam | Levetiracetam | 68 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | 12 |
| Alprazolam | Alprazolam | 63 | 16 |
| Lactulose | Lactulose | 63 | 15 |
| Benztropine Mesylate | Benztropine Mesylate | 60 | 11 |
| Prednisone | Prednisone | 59 | 13 |
| Ezetimibe | Ezetimibe | 58 | 21 |
| Nifedipine Er | Nifedipine | 55 | suppressed |
| Spironolactone | Spironolactone | 55 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 53 | 13 |
| Valsartan | Valsartan | 52 | suppressed |
| Meloxicam | Meloxicam | 51 | 15 |
| Myrbetriq | Mirabegron | 50 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 50 | suppressed |
| Cephalexin | Cephalexin | 49 | 32 |
| Olanzapine | Olanzapine | 48 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 47 | 12 |
| Farxiga | Dapagliflozin Propanediol | 46 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 46 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | 11 |
| Allopurinol | Allopurinol | 44 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | 13 |
| Insulin Lispro | Insulin Lispro | 40 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 40 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 39 | suppressed |
| Xifaxan | Rifaximin | 39 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 39 | suppressed |
| Lamotrigine | Lamotrigine | 38 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 37 | suppressed |
| Lovastatin | Lovastatin | 37 | suppressed |
| Synthroid | Levothyroxine Sodium | 37 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 33 | 15 |
| Bupropion Xl | Bupropion Hcl | 32 | 12 |
| Nystatin | Nystatin | 32 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Azithromycin | Azithromycin | 29 | 20 |
| Carbamazepine | Carbamazepine | 29 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 28 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 28 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 28 | 14 |
| Buspirone Hcl | Buspirone Hcl | 28 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 27 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 27 | suppressed |
| Rivastigmine | Rivastigmine | 27 | suppressed |
| Lansoprazole | Lansoprazole | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Sucralfate | Sucralfate | 26 | suppressed |
| Glimepiride | Glimepiride | 25 | suppressed |
| Lorazepam | Lorazepam | 25 | 14 |
| Methocarbamol | Methocarbamol | 24 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 24 | suppressed |
| Torsemide | Torsemide | 24 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 23 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 22 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 21 | suppressed |
| Ibuprofen | Ibuprofen | 21 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 21 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 21 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 20 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 20 | suppressed |
| Methimazole | Methimazole | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | 17 |
| Enoxaparin Sodium | Enoxaparin Sodium | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Multaq | Dronedarone Hcl | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 16 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 16 |
| Baclofen | Baclofen | 16 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 16 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Nystop | Nystatin | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | 11 |
| Trintellix | Vortioxetine Hydrobromide | 15 | suppressed |
| Alphagan P | Brimonidine Tartrate | 14 | suppressed |
| Celecoxib | Celecoxib | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Bystolic | Nebivolol Hcl | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Fluorometholone | Fluorometholone | 11 | suppressed |
| Gemtesa | Vibegron | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $212.66 · 4 records | Abbott Laboratories | Cologuard Collection Kit, NAVITOR, REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error